Charles Schwab’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.57M | Buy |
|
|||||
|
2025
Q2 | $1.79M | Sell |
|
|||||
|
2025
Q1 | $1.04M | Sell |
|
|||||
|
2024
Q4 | $1.42M | Buy |
|
|||||
|
2024
Q3 | $1.14M | Buy |
|
|||||
|
2024
Q2 | $1.17M | Buy |
|
|||||
|
2024
Q1 | $2.06M | Buy |
|
|||||
|
2023
Q4 | $1.81M | Buy |
|
|||||
|
2023
Q3 | $572K | Hold |
|
|||||
|
2023
Q2 | $622K | Buy |
|
|||||
|
2023
Q1 | $210K | Hold |
|
|||||
|
2022
Q4 | $249K | Buy |
|
|||||
|
2022
Q3 | $545K | Sell |
|
|||||
|
2022
Q2 | $544K | Buy |
|
|||||
|
2022
Q1 | $818K | Buy |
|
|||||
|
2021
Q4 | $664K | Buy |
|
|||||
|
2021
Q3 | $545K | Hold |
|
|||||
|
2021
Q2 | $470K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $8K | Hold |
|
|||||
|
2020
Q2 | $12K | Sell |
|
|||||
|
2020
Q1 | $146K | Sell |
|
|||||
|
2019
Q4 | $223K | Hold |
|
|||||
|
2019
Q3 | $260K | Hold |
|
|||||
|
2019
Q2 | $236K | Buy |
|
|||||
|
2019
Q1 | $27K | Hold |
|
|||||
|
2018
Q4 | $28K | Buy |
|